PO10.7 Prognostic Factors of Mortality and Morbidity in Thai Adult Status Epilepticus

2009 ◽  
Vol 120 ◽  
pp. S75
Author(s):  
Charungthai Dejthevaporn
2021 ◽  
pp. 153575972199832
Author(s):  
Karnig Kazazian ◽  
Marissa Kellogg ◽  
Nora Wong ◽  
Krista Eschbach ◽  
Raquel Farias Moeller ◽  
...  

New-onset refractory status epilepticus (NORSE) is a rare clinical presentation of refractory status epilepticus (RSE) that occurs in people without active epilepsy or preexisting neurologic disorder. Febrile infection-related epilepsy syndrome (FIRES) is a subcategory of NORSE. New-onset refractory status epilepticus/FIRES are becoming increasingly recognized; however, information pertaining to disease course, clinical outcomes, and survivorship remains limited, and mortality and morbidity are variable, but often high. The objective of the NORSE/FIRES Family Registry is to (1) provide an easily accessible and internationally available multilingual registry into which survivors or NORSE/FIRES surrogates or family members of people affected by NORSE/FIRES or their physicians can enter data in a systematic and rigorous research study from anywhere in the world where internet is available; and (2) to examine past medical history, outcomes, and quality of life for people affected by NORSE/FIRES.


2021 ◽  
Vol 10 (4) ◽  
pp. 881
Author(s):  
Jason B. Katz ◽  
Kent Owusu ◽  
Ilisa Nussbaum ◽  
Rachel Beekman ◽  
Nicholas A. DeFilippo ◽  
...  

Background: Status epilepticus (SE) carries an exceedingly high mortality and morbidity, often warranting an aggressive therapeutic approach. Recently, the implementation of a ketogenic diet (KD) in adults with refractory and super-refractory SE has been shown to be feasible and effective. Methods: We describe our experience, including the challenges of achieving and maintaining ketosis, in an adult with new onset refractory status epilepticus (NORSE). Case Vignette: A previously healthy 29-year-old woman was admitted with cryptogenic NORSE following a febrile illness; course was complicated by prolonged super-refractory SE. A comprehensive work-up was notable only for mild cerebral spinal fluid (CSF) pleocytosis, elevated nonspecific serum inflammatory markers, and edematous hippocampi with associated diffusion restriction on magnetic resonance imaging (MRI). Repeat CSF testing was normal and serial MRIs demonstrated resolution of edema and diffusion restriction with progressive hippocampal and diffuse atrophy. She required prolonged therapeutic coma with high anesthetic infusion rates, 16 antiseizure drug (ASD) trials, empiric immunosuppression and partial bilateral oophorectomy. Enteral ketogenic formula was started on hospital day 28. However, sustained beta-hydroxybutyrate levels >2 mmol/L were only achieved 37 days later following a comprehensive adjustment of the care plan. KD was challenging to maintain in the intensive care unit (ICU) and was discontinued due to poor nutritional state and pressure ulcers. KD was restarted again in a non-ICU unit facilitating ASD tapering without re-emergence of SE. Discussion: There are inconspicuous carbohydrates in commonly administered medications for SE including antibiotics, electrolyte repletion formulations, different preparations of the same drug (i.e., parenteral, tablet, or suspension) and even solutions used for oral care―all challenging the use of KD in the hospitalized patient. Tailoring comprehensive care and awareness of possible complications of KD are important for the successful implementation and maintenance of ketosis.


2020 ◽  
Vol 14 (1) ◽  
pp. 95-102
Author(s):  
Mohammad Vafaee-Shahi ◽  
Elaheh Soltanieh ◽  
Hossein Saidi ◽  
Aina Riahi

Background: Risk factors identification associated with status epilepticus is valuable in order to prevent morbidity and mortality in children. This study aimed to consider the etiology, risk factors, morbidity and mortality in children with status epilepticus. Methods: This retrospective cross-sectional study was performed on 119 patients aged from one month old to 15 years old. Patients’ data were recorded, including basic demographic, etiology and clinical information. The different risk factors correlated to morbidity and mortality were evaluated in this study. Results: The most common etiologies were acute symptomatic and febrile status epilepticus by 32.8% and 22.7%, respectively. Abnormal brain imaging results were reported far more frequently in patients with a history of neurodevelopmental delay and previous status epilepticus (p<0.001). The overall morbidity and mortality rates were 18.9% and 10.9%, respectively; while these rates in patients with delayed development (45.16% and 18.42%, respectively) were significantly higher than patients with normal development (8% and 7.4%, respectively). The morbidity rates in patients with previous seizures and previous status epilepticus were remarkably higher than those without previous history of seizure (26.41% vs 11.32%; p=0.047) and without previous status epilepticus (36.36% versus 14.28%; p=0.018). The length of hospital stay in patients with mortality was considerably longer than patients without mortality (12.30 ± 16.1 days vs 7.29 ± 6.24 days; p=0.033). The mortality rate in patients with normal Lumbar Puncture result was notably lower than those with abnormal LP result (2.9% vs 50%). The morbidity rate in patients with abnormal brain imaging results (p<0.001) was significantly greater than those in patients with normal results. The mortality rate was relatively higher in patients with abnormal imaging results compared to those normal results. Etiology was an important predictor of mortality and morbidity rates; acute symptomatic (32.8%), febrile status epilepticus (22.7%) and remote symptomatic (16.8%) etiologies were the most common underlying causes of S.E. While in children less than 3 years old, the acute symptomatic etiology and febrile status epilepticus etiologies were estimated as the most common, in most patients older than 3 years old the most common etiology of status epilepticus was unknown. Congenital brain defects etiology had the highest mortality (36.36%) and morbidity (42.85%) rate. The lowest morbidity (3.84%) and mortality (0%) rates were for patients with febrile status epilepticus etiology. Conclusion: Age, developmental delay, history of previous status epilepticus, the length of hospital stay, abnormal brain imaging results and the underlying etiology of status epilepticus were associated with increased morbidity and mortality among children with status epilepticus.


PEDIATRICS ◽  
1989 ◽  
Vol 84 (5) ◽  
pp. 939-940
Author(s):  
JEAN AICARDI ◽  
JEAN-JACQUES CHEVRIE

Concerning the article by Maytal and colleagues and the accompanying editorial by Freeman, we have also found that the mortality and morbidity of cryptogenic status epilepticus has decreased considerably since our 1970 paper. Likewise, the incidence of acquired hemiplegia in France has become low during the same period. Contrary to Maytal et al, however, we believe that better and earlier control of convulsive status has played a role in this decrease. There is considerable evidence that convulsive seizures can produce brain damage, irrespective of the cause of attacks.


2019 ◽  
pp. 629-650
Author(s):  
Pete Murphy ◽  
Sarah Stibbards

This chapter is meant as a brief guide to the immediate management of medical emergencies that an anaesthetist may be called to assist with. It is not intended as an in-depth text on the conditions covered. The severity and immediate management of acute asthma are detailed, including tips on induction and ventilation strategies. An overview of bronchiolitis includes presentation, risk factors, medical management, and tips on intubation and ventilation. Convulsive status epilepticus is a common referral, and its causes, treatment and indications for intubation and early extubation are discussed. Diabetic ketoacidosis management is described, specifically including the treatment of cerebral oedema. A common cause of mortality and morbidity in children is sepsis, and in this final section of the chapter the ‘Sepsis 6’ approach is taken.


2019 ◽  
Vol 101 ◽  
pp. 106745
Author(s):  
Nicola Pietrafusa ◽  
Marina Trivisano ◽  
Luca De Palma ◽  
Marcello Bellusci ◽  
Lucia Fusco ◽  
...  

Epilepsia ◽  
2019 ◽  
Vol 60 (12) ◽  
pp. 2486-2498 ◽  
Author(s):  
Nicola Specchio ◽  
Nicola Pietrafusa ◽  
Marcello Bellusci ◽  
Marina Trivisano ◽  
Antonella Benvenga ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document